Search Results 181-190 of 17429 for PID Treatment

  1. Vedolizumab IV 300 Mg In The Treatment Of Fistulizing Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate perianal fistula healing at Week 30 in 2 different dose regimens of vedolizumab intravenous (IV) 300 milligram (mg) in ...

  2. A Study to Evaluate the Effectiveness of Antihistamines in the Treatment of Eosinophilic Esophagitis - Mayo Clinic

    The purpose of this study is to assess the effectiveness of antihistamines in the treatment of eosinophilic esophagitis. Participation eligibility. Participant ...

  3. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

  4. Pelvic organ prolapse - Symptoms and causes - Mayo Clinic

    Pelvic organ prolapse can be treated. Often, nonsurgical treatment helps. Sometimes, surgery might be needed to put the pelvic organs back in place ...

  5. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑Controlled Phase-III STudy - Mayo Clinic

    COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo‑ ...

  6. Factors related to jaundice and transplant-free survival in patients with PSC who receive endoscopic treatment - Mayo Clinic

    Treatment of flow-limiting biliary strictures with endoscopic retrograde cholangiopancreatography (ERCP) has the potential to resolve jaundice in those with ...

  7. A Study Of HISTOTRIPSY For Abdominal Tumor Treatment - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease - Mayo Clinic

    Although all subjects will receive active treatment, this study is double-blinded for the entire 208 weeks for the purpose of preserving the blind of the ...

  9. Emricasan, A Caspase Inhibitor, For Treatment Of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study Comparing Standard Treatment versus Accelerated Initiation of Renal Replacement Therapy for Acute Kidney Injury - Mayo Clinic

    The purpose of this study is to determine if, in critically ill patients with severe acute kidney injury, an earlier start of renal replacement therapy compared ...